Organic Letters
Letter
(
9) (a) Doyle, M. P.; Pieters, R. J.; Martin, S. F.; Austin, R. E.;
AUTHOR INFORMATION
■
Oalmann, C. J.; Mueller, P. J. Am. Chem. Soc. 1991, 113, 1423−1424.
b) Zhu, B.-H.; Zhou, R.; Zheng, J.-C.; Deng, X.-M.; Sun, X.-L.; Shen,
Corresponding Author
(
Q.; Tang, Y. J. Org. Chem. 2010, 75, 3454−3457. (c) Beaulieu, L.-P.
B.; Zimmer, L. E.; Gagnon, A.; Charette, A. B. Chem. - Eur. J. 2012,
1
8, 14784−14791.
10) (a) Shuto, S.; Ono, S.; Hase, Y.; Kamiyama, N.; Takada, H.;
Yamasihita, K.; Matsuda, A. J. Org. Chem. 1996, 61, 915−923.
b) Kazuta, Y.; Matsuda, A.; Shuto, S. J. Org. Chem. 2002, 67, 1669−
677. (c) Yoshida, K.; Yamaguchi, K.; Sone, T.; Unno, Y.; Asai, A.;
Yokosawa, H.; Matsuda, A.; Arisawa, M.; Shuto, S. Org. Lett. 2008, 10,
571−3574. (d) Tanabe, M.; Watanabe, M.; Hoshiya, N.; Mizuno, A.;
Fukuda, H.; Arisawa, M.; Shuto, S. J. Org. Chem. 2013, 78, 11714−
1720. (e) Yotsuji, K.; Hoshiya, N.; Kobayashi, T.; Fukuda, H.; Abe,
ORCID
(
Author Contributions
(
1
3
The manuscript was written through contributions of all
authors. All authors have given approval to the final version of
the manuscript.
1
H.; Arisawa, M.; Shuto, S. Adv. Synth. Catal. 2015, 357, 1022−1028.
(11) (a) Hoshiya, N.; Takenaka, K.; Shuto, S.; Uenishi, J. Org. Lett.
Notes
2
016, 18, 48−51. (b) Hoshiya, N.; Kobayashi, T.; Arisawa, M.; Shuto,
The authors declare no competing financial interest.
S. Org. Lett. 2013, 15, 6202−6205. (c) Hoshiya, N.; Kondo, M.;
Fukuda, H.; Arisawa, M.; Uenishi, J.; Shuto, S. J. Org. Chem. 2017, 82,
2535−2544.
ACKNOWLEDGMENTS
■
(
12) Synthesis of racemic 1,2-disubstituted cyclopropanes via
This work was supported by MEXT/JSPS KAKENHI Grant
Nos. JP15H02495 (to S.S.) and JP17K15476 (to M.W.), a
research grant from the Takeda Science Foundation (to
M.W.), and partly by Platform Project for Supporting Drug
Discovery and Life Science Research (BINDS) from AMED
under Grant No. JP18am0101093. We are grateful to Sanyo
Fine Co., Ltd. for the gift of the enantiomerically pure
epichlorohydrin.
3
C(sp )−H activation using 8-aminoquinoline auxiliary as a directing
group. See: (a) Parella, R.; Gopalakrishnan, B.; Babu, S. A. Org. Lett.
2
2
013, 15, 3238. (b) Shan, G.; Huang, G.; Rao, Y. Org. Biomol. Chem.
015, 13, 697−701.
13) Fawcett, A.; Pradeilles, J.; Wang, Y.; Mutsuga, T.; Myers, E. L.;
(
Aggarwal, V. K. Science 2017, 357, 283−286.
14) He, J.; Wasa, M.; Chan, K. S. L.; Shao, Q.; Yu, J.-Q. Chem. Rev.
2017, 117, 8754−8786.
15) (a) Zaitsev, V. G.; Shabashov, D.; Daugulis, O. J. Am. Chem.
(
(
Soc. 2005, 127, 13154−13155. (b) Daugulis, O.; Do, H.-Q.;
Shabashov, D. Acc. Chem. Res. 2009, 42, 1074−1086. (c) Daugulis,
O.; Roane, J.; Tran, L. D. Acc. Chem. Res. 2015, 48, 1053−1064.
REFERENCES
1) Boutureira, O.; Matheu, M. I.; Díaz, Y.; Castillon
Rev. 2013, 42, 5056−5072.
2) Bisacchi, G. S.; Chao, S. T.; Bachard, C.; Daris, J. P.; Innaimo, S.;
■
(
́
, S. Chem. Soc.
(d) He, G.; Wang, B.; Nack, W. A.; Chen, G. Acc. Chem. Res. 2016,
(
4
(
9, 635−645.
Jacobs, G. A.; Kocy, O.; Lapointe, P.; Martel, A.; Merchant, Z.;
Slusarchyk, W. A.; Sundeen, J. E.; Young, M. G.; Colonno, R.; Zahler,
R. Bioorg. Med. Chem. Lett. 1997, 7, 127−132.
16) Willwacher, J.; Heggen, D.-I. B.; Wirtz, C.; Thiel, W.; Furstner,
̈
A. Chem. - Eur. J. 2015, 21, 10416−10430.
(
(
17) Armstrong, A.; Scutt, J. N. Org. Lett. 2003, 5, 2331−2334.
18) Zhang, S.-Y.; He, G.; Nack, W. A.; Zhao, Y.; Li, Q.; Chen, G. J.
(
3) Daluge, S. M.; Good, S. S.; Faletto, M. B.; Miller, W. H.; St Clair,
M. H.; Boone, L. R.; Tisdale, M.; Parry, N. R.; Reardon, J. E.;
Dornsife, R. E.; Averett, D. R.; Krenitsky, T. A. Antimicrob. Agents
Chemother. 1997, 41, 1082−1093.
Am. Chem. Soc. 2013, 135, 2124−2127.
19) This regioselective and stereoselective substitution reaction is
(
thought to proceed via a 5-membered palladacycle intermediate. See:
(
4) (a) Shuto, S.; Obara, T.; Toriya, M.; Hosoya, M.; Snoeck, R.;
Shabashov, D.; Daugulis, O. J. Am. Chem. Soc. 2010, 132, 3965−3972.
Andrei, G.; Balzarini, J.; De Clercq, E. J. Med. Chem. 1992, 35, 324−
31. (b) Shuto, S.; Obara, T.; Saito, G.; Andrei, G.; Snoeck, R.; De
(
20) (a) Dey, S.; Garner, P. J. Org. Chem. 2000, 65, 7697−7699.
3
(
b) Frieden, M.; Giraud, M.; Reese, C. B.; Song, Q. J. Chem. Soc.,
Clercq; Matsuda, A. J. Med. Chem. 1996, 39, 2392−2399. (c) Obara,
T.; Shuto, S.; Saito, G.; Snoeck, R.; Andrei, G.; Balzarini, J.; De
Clercq; Matsuda, A. J. Med. Chem. 1996, 39, 3847−3852.
Perkin Trans. 1 1998, 2827−2832. (c) Ahn, H.; Choi, T. H.; De
Castro, K.; Lee, K. C.; Kim, B.; Moon, B. S.; Hong, S. H.; Lee, J. C.;
Chun, K. S.; Cheon, G. J.; Lim, S. M.; An, G., II; Rhee, H. J. Med.
Chem. 2007, 50, 6032−6038. (d) Beadle, J. R.; Hostetler, K. PCT Int.
(
1
(
5) Mizuno, A.; Matsui, K.; Shuto, S. Chem.Eur. J. 2017, 23,
4394−14409 and references cited therein .
Appl. WO 2005087788 A2, 2005.
6) (a) Ashton, W. T.; Meurer, L. C.; Cantone, C. L.; Field, A. K.;
6
(
21) Employing N -Boc-protected adenine effectively improve the
Hannah, J.; Karkas, J. D.; Liou, R.; Patel, G. F.; Perry, H. C.; Wagner,
A. F.; Walton, E.; Tolman, R. L. J. Med. Chem. 1988, 31, 2304−2315.
b) Sekiyama, T.; Hatsuya, S.; Tanaka, Y.; Uchiyama, M.; Ono, N.;
Iwayama, S.; Oikawa, M.; Suzuki, K.; Okunishi, M.; Tsuji, T. J. Med.
Chem. 1998, 41, 1284−1298. (c) Zhou, S.; Breitenbach, J. M.;
Borysko, K. Z.; Drach, J. C.; Kern, E. R.; Gullen, E.; Cheng, Y.-C.;
Zemlicka, J. J. Med. Chem. 2004, 47, 566−575. (d) Choi, J.-R.; Cho,
D.-G.; Roh, K. Y.; Hwang, J.-T.; Ahn, S.; Jang, H. S.; Cho, W.-Y.; Kim,
K. W.; Cho, Y.-G.; Kim, J.; Kim, Y.-Z. J. Med. Chem. 2004, 47, 2864−
9
N -regioselectivity in the Mitsunobu reaction. See: Yin, X.-q.; Li, W.-
k.; Schneller, S. W. Tetrahedron Lett. 2006, 47, 9187−9189.
(
(
22) In the synthesis of IId, the MMTr group was removed by a
three-component reagent system. See: Kicsak
M.; Csavas, M.; Herczeg, M.; Kupihar, Z.; Kovac
Herczegh, P. Org. Biomol. Chem. 2016, 14, 3190−3192.
23) In the protecting groups removing steps for 14a and 14b,
́
, M.; Bege, M.; Bereczki,
́
́
́
́
s, L.; Borbas, A.;
́
(
undesired nucleobase elimination was occurred to lower the yield.
2
(
869.
7) Boyd, M. R.; Bacon, T. H.; Sutton, D.; Cole, M. Antimicrob.
Agents Chemother. 1987, 31, 1238−1242.
8) (a) Katagiri, N.; Sato, H.; Kaneko, C. Chem. Pharm. Bull. 1990,
8, 3184−3186. (b) Katagiri, N.; Sato, H.; Kaneko, C. Nucleosides
Nucleotides 1992, 11, 707−718. (c) Cluet, F.; Haudrechy, A.; Le Ber,
P.; Sinay
(
3
̈
, P.; Wick, A. Synlett 1994, 1994, 913−915. (d) Gauvry, N.;
Huet, F. Tetrahedron 1999, 55, 1321−1328. (e) Huang, K.-X.; Xie,
M.-S.; Zhao, G.-F.; Qu, G.-R.; Guo, H.-M. Adv. Synth. Catal. 2016,
358, 3627−3632.
D
Org. Lett. XXXX, XXX, XXX−XXX